Christopher M. Bruno

Christopher M. Bruno's patent caseload has included complex litigation involving pharmaceutical, immunology, medical device, agritech, and computing systems technologies. Read Christopher M. Bruno's full bio.
Senate Committee Advances Bills to Tackle High Drug Prices, Enhance Market Competition
By Christopher M. Bruno on Apr 18, 2025
Posted In Employee Benefits, Health and Welfare Plans
The US Senate Judiciary Committee has advanced six bills aimed at reducing pharmaceutical prices and improving market competitiveness. These bills address various issues, including limiting the number of patents a biologics license holder can assert in litigation, clarifying the boundaries of permissible settlements in “pay for delay” agreements, and preventing “product hopping” by branded drug...
Continue Reading